首页> 外国专利> MARKER GENES BASED ON DAUNORUBICIN TREATMENT FOR SCREENING OF DRUG INDUCING CARDIO TOXICITY AND SCREENING METHOD USING THEREOF

MARKER GENES BASED ON DAUNORUBICIN TREATMENT FOR SCREENING OF DRUG INDUCING CARDIO TOXICITY AND SCREENING METHOD USING THEREOF

机译:基于多柔比星治疗的MARKER基因筛查药物致心脏毒性的方法及其筛选方法

摘要

The present invention relates to a marker gene for cardiovascular toxicity-inducing drug search and a search method using the same, and more particularly, to a marker gene in which gene expression is increased or decreased by cardiovascular toxicity-inducing drug Daunorubicin, and a cardiovascular system using the same. The present invention relates to a method of searching for a toxic drug. The marker gene of the present invention can be usefully used for monitoring and determining drugs or chemicals having a risk of cardiovascular toxicity by using the response genes selected through the DNA microarray chip as marker genes. It can be used as a tool to identify mechanisms of action that cause side effects.;Daunorubicin, marker gene, microarray, cardiovascular toxicity
机译:本发明涉及用于心血管毒性诱导药物搜索的标记基因和使用该标记基因的搜索方法,更具体地,涉及其中通过心血管毒性诱导药物柔红霉素增加或降低基因表达的标记基因,以及心血管疾病系统使用相同。本发明涉及一种寻找有毒药物的方法。通过使用通过DNA微阵列芯片选择的应答基因作为标记基因,本发明的标记基因可有效地用于监测和确定具有心血管毒性风险的药物或化学药品。它可用作鉴定引起副作用的作用机制的工具。柔红霉素,标记基因,微阵列,心血管毒性

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号